Autolus Therapeutics Financial Overview
Autolus Therapeutics's market cap is currently $415.18M. The company's EPS TTM is $-0.3; its P/E ratio is ―; Autolus Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
